City of Hope

www.cityofhope.org

 

City of Hope
A

Cardiac Safety of Zanubrutinib vs. Other BTKis in CLL

By City of Hope FEATURING Alexey Danilov
By City of Hope FEATURING Alexey Danilov
577 views
June 23, 2023
1 Comment
Login to view comments. Click here to Login

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay
Lymphoma
10:57
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Mosunetuzumab + Polatuzumab Vedotin in Pts …

Feat. E. Budde
10:21
SOHO 2023 Eleventh Annual Meeting

SOHO 2023 Next Questions: HL

Feat. A. Herrera
19:32
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: Tailoring Therapy for PTCL

Feat. J. Zain
10:33
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: A Multidisciplinary Approach to the Management of Mycosis…

Feat. C. Querfeld
06:21
City of Hope

Cardiac Safety of Zanubrutinib vs. Other BTKis in CLL

Feat. A. Danilov
12:24
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Real-World Outcomes of Brexu-Cel for R/R …

Feat. S. Kambhampati
06:50
ecancer

ASCO® 2023 Insights: "S1826 Study Summary - Nivolumab-AVD vs. B…

Feat. A. Herrera
06:16
City of Hope

Current Perspective on CAR-T Therapy in Mantle Cell Lymphoma

Feat. A. Danilov
07:48
City of Hope

Tolerability of BTKi in R/R MCL

Feat. T. Phillips
18:31
City of Hope

Novel Treatment Options for DLBCL - Overview of Targeted Therapies a…

Feat. J. Zain
30:08
City of Hope

Advances in Therapy in Cutaneous T Cell Lymphoma

Feat. C. Querfeld